Hybrid molecules between benzenesulfonamides and active antimicrobial benzo[d]isothiazol-3-ones

European Journal of Medicinal Chemistry

Volumn 44, Issue 6, 2009, Pages 2741-2747

  Zani, Franca ^a   Incerti, Matteo ^a   Ferretti, Rocco ^a   Vicini, Paola ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

2 Amino benzo d isothiazol 3 one derivatives; Antimicrobial activity; Benzo d isothiazol 3 one benzenesulfonamides; Hybrid molecules

Indexed keywords

2 (4 AMINOBENZENESULFONYL)AMINO 5 METHYL BENZO[D]ISOTHIAZOL 3 ONE; 2 (4 AMINOBENZENESULFONYL)AMINO BENZO[D]ISOTHIAZOL 3 ONE; 2 (4' ACETYLAMINOBENZENESULFONYL)AMINO 5 METHYL BENZO[D]ISOTHIAZOL 3 ONE; 2 (4' ACETYLAMINOBENZENESULFONYL)AMINO BENZO[D]ISOTHIAZOL 3 ONE; 2 (BIS 4' ACETYLAMINOBENZENESULFONYL)AMINO 5 METHYL BENZO[D]ISOTHIAZOL 3 ONE; 2 (BIS 4' ACETYLAMINOBENZENESULFONYL)AMINO BENZO[D]ISOTHIAZOL 3 ONE; 2 (BIS 4' AMINOBENZENESULFONYL)AMINO BENZO[D]ISOTHIAZOL 3 ONE; 2 (BIS-4' AMINOBENZENESULFONYL)AMINO-5-METHYL BENZO[D]ISOTHIAZOL 3 ONE; AMPICILLIN; SULFAMETHOXAZOLE; SULFONAMIDE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BACILLI; CRYPTOCOCCUS NEOFORMANS; DERMATOPHYTE; DRUG POTENTIATION; DRUG SYNTHESIS; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; HYBRID; MINIMUM INHIBITORY CONCENTRATION; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BACILLUS; CRYPTOCOCCUS NEOFORMANS; DOSE-RESPONSE RELATIONSHIP, DRUG; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; SACCHAROMYCES CEREVISIAE; STAPHYLOCOCCUS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES; THIAZOLES;

EID: 64449087690     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.07.022     Document Type: Article

References (32)

1. Clerici F., Gelmi M.L., Pellegrino S., and Pocar D. Top. Heterocycl. Chem. 9 (2007) 179-264
2. Siegemund A., Taubert K., and Schulze B. Sulfur Rep. 23 (2002) 279-319
3. Vicini P., Amoretti L., Ballabeni V., Tognolini M., and Barocelli E. Bioorg. Med. Chem. 8 (2000) 2355-2358
4. Ballabeni V., Tognolini M., Calcina F., Impicciatore M., Vicini P., and Barocelli E. Pharmacol. Res. 46 (2002) 389-393
5. Borgna P., Carmellino M.L., Natangelo M., Pagani G., Pastoni F., Pregnolato M., and Terreni M. Eur. J. Med. Chem. 31 (1996) 919-925
6. Mor M., Zani F., Mazza P., Silva C., Bordi F., Morini G., and Plazzi P.V. Il Farmaco 51 (1996) 493-501
7. Zani F., Mingiardi M.R., Maggiali C.A., and Mazza P. Il Farmaco 51 (1996) 707-713
8. Carmellino M.L., Pagani G., Terreni M., Pregnolato M., Borgna P., Pastoni F., and Zani F. Il Farmaco 52 (1997) 359-366
9. Zani F., Pregnolato M., and Zampollo F. Il Farmaco 54 (1999) 643-647
10. Vicini P., Zani F., Cozzini P., and Doytchinova I. Eur. J. Med. Chem. 37 (2002) 553-564
11. Zani F., Vicini P., and Incerti M. Eur. J. Med. Chem. 39 (2004) 135-140
12. Anand N., and Remers W.A. Burger's Medicinal Chemistry and Discovery. In: Abraham D.J. (Ed). Chemotherapeutic Agents. sixth ed. vol. 5 (2003), Wiley and Sons, New York 557-582
13. Grimm H., and Fell J.J. Med. Klin. (Munich) 75 (1980) 726-727
14. Zhang J., Zhang M., Gu Y., Zhang Y., Zhou D., and Dai Z. Zhonghua Yixue Jianyan Zazhi 4 (1981) 219-222
15. Seydel J.K., and Schaper K.J. Drug Dev. Eval. 7 (1981) 17-31
16. Wysor M.S., and Scovill J.P. Drug Exp. Clin. Res. 8 (1982) 155-168
17. Tironi C., Fruttero R., and Garrone A. Il Farmaco 45 (1990) 473-478
18. Richards R.M.E., Taylor R.B., and Xing D.K.L. J. Pharm. Sci. 80 (1991) 861-867
19. van Duijkeren E., van Klingeren B., Vulto A.G., Sloet van Oldruitenborgh-Oosterbaan M.M., Breukink H.J., and van Miert A.S.J.P.A.M. Am. J. Vet. Res. 55 (1994) 1386-1390
20. Brunpascaud M., Chau F., Garry L., Farinotti R., Derovin F., and Girard P.M. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 (1996) 201-207
21. Wininger D.A., and Fass R.J. Antimicrob. Agents Chemother. 46 (2002) 594-597
22. Nieto M.J., Alovero F.L., Manzo R.H., and Mazzieri M.R. Eur. J. Med. Chem. 34 (1999) 209-214
23. Nieto M.J., Alovero F.L., Manzo R.H., and Mazzieri M.R. Eur. J. Med. Chem. 40 (2005) 361-369
24. Bukvic K.M., Novak P., Cindric M., Brajsa K., Dumic M., and Kujundzic N. Eur. J. Med. Chem. 42 (2007) 138-145
25. Zani F., and Vicini P. Arch. Pharm. Pharm. Med. Chem. 331 (1998) 219-223
26. Wermuth C.G. Drug Discov. Today 9 (2004) 826-827
27. Vicini P., Manotti C., Caretta A., and Amoretti L. Arzn.-Forsch. Drug Res. 47 (1997) 1218-1221
28. Fuller S.J., Denyer S.P., Hugo W.B., Pemberton D., Woodcock P.M., and Buckley A.J. Lett. Appl. Microbiol. 1 (1985) 13-15
29. Collier P.J., Ramsey A.J., Austin P., and Gilbert P. J. Appl. Bacteriol. 69 (1990) 569-577
30. Jorgensen J.H., et al. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of Clinical Microbiology (1999), American Society of Microbiology, Washington, DC 1526-1554 and 1640-1652
31. Eliopoulos G.M., and Moellering Jr. R.C. In: Lorian V. (Ed). Antibiotics in Laboratory Medicine (1991), Williams & Wilkins, Baltimore 432-492
32. Meletiadis J., Meis J.F.G.M., Mouton J.W., and Verweij P.E. Rev. Med. Microbiol. 13 (2002) 101-117